These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. van Son WJ; Peset R; Duipmans JC; van der Mark TW; The TH; Tegzess AM Transplantation; 1987 Jul; 44(1):149-50. PubMed ID: 3037737 [No Abstract] [Full Text] [Related]
49. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
55. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD; O'Rourke E Transplant Proc; 1994 Oct; 26(5 Suppl 1):23-7. PubMed ID: 7940972 [No Abstract] [Full Text] [Related]
56. A cytomegalovirus vaccine tames the troll of transplantation. Schleiss MR Lancet; 2011 Apr; 377(9773):1216-8. PubMed ID: 21481691 [No Abstract] [Full Text] [Related]
57. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques. Jankowski M; Styczyński P Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198 [TBL] [Abstract][Full Text] [Related]
58. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor. Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565 [No Abstract] [Full Text] [Related]
59. Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. Snydman DR; Werner BG; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS; Strom TB; Carpenter CB Transplant Proc; 1991 Feb; 23(1 Pt 2):1357-60. PubMed ID: 1846464 [No Abstract] [Full Text] [Related]
60. Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation. Leone F; Gigliotti P; Mauro MV; Lofaro D; Greco F; Tenuta R; Perugini D; Papalia T; Mollica A; Perri A; Vizza D; La Russa A; Toteda G; Lupinacci S; Giraldi C; Bonofiglio R Transpl Infect Dis; 2016 Apr; 18(2):191-201. PubMed ID: 26878346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]